Journal profile · Rehabilitation
European Journal of Cancer Care
ISSN 0961-5423 · eISSN 1365-2354 · Wiley-Blackwell Publishing Ltd · ENGLAND · Bimonthly · Founded 1991
European Journal of Cancer Care: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1; subscription journal; APC about USD 2,490; median 188 days to acceptance (98 articles, last 24 months); community-reported acceptance: about 75%; 112 articles in 2025; indexed in SCIE, SSCI and Scopus; the journal's website says it has moved to a new publisher.
The journal's website says it has moved to a new publisher: As of Mar 30 th, 2026, European Journal of Cancer Care will no longer be published by Wiley. More information can be found on the new publisher's website: https://www.maxapress.com/ejcc. Source ↗Publisher website ·
Scope
Aims, scope and focus
European Journal of Cancer Care is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer survivorship and care, Palliative Care and End-of-Life Issues and Childhood Cancer Survivors' Quality of Life, together about 45.5% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
The European Journal of Cancer Care aims to encourage comprehensive, multiprofessional cancer care across Europe and internationally.
From the journal's Aims & Scope
Research area (LetPub): Rehabilitation
Editor-in-chief David WellerPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer survivorship and careMedicine22%
- Palliative Care and End-of-Life IssuesMedicine12.9%
- Childhood Cancer Survivors' Quality of LifeMedicine10.6%
- Family Support in IllnessSocial Sciences7.7%
- Global Cancer Incidence and ScreeningMedicine6.7%
- Patient-Provider Communication in HealthcareHealth Professions6.5%
- Cancer-related cognitive impairment studiesMedicine2.9%
- Economic and Financial Impacts of CancerEconomics, Econometrics and Finance2.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Nursing | Zone 3 |
| Minor | Health Care Sciences & Services | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Rehabilitation | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Health Care Sciences & Services | Zone 4 |
| Minor | Nursing | Zone 3 |
| Minor | Rehabilitation | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Nursing | Zone 3 |
| Minor | Health Care Sciences & Services | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Rehabilitation | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIESSCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1LetPub ·
- CiteScore 2026-06
- 4.4LetPub ·
- SJR 2026-06
- 0.75LetPub ·
- SNIP 2026-06
- 0.93LetPub ·
- h-index
- 59LetPub ·
- h-index
- 104OpenAlex ·
- i10-index
- 1,919OpenAlex ·
- 2-year mean citedness
- 0.79OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 99.52%LetPub ·
Volume
- Articles per year
- 109LetPub ·
Articles by year OpenAlex count · 3,809 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 52 | 43 | 8 |
| 2025 | 112 | 111 | 80 |
| 2024 | 47 | 46 | 78 |
| 2023 | 55 | 54 | 154 |
| 2022 | 220 | 177 | 2,141 |
| 2021 | 156 | 127 | 1,992 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
188 daysMedian, submission to acceptance · P25–P75 127 days – 250 days
- Acceptance to online
- median 26 days (98 articles)
- Submission to online
- median 211 days
- Sample
- 98 articles with submission and acceptance dates (147 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,490 / EUR 2,160 / GBP 1,830 | — | — | |
| Publisher website | USD 2,300 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 200 words
- Manuscript length
- ≤ 4,000 words
- Reference style
- Vancouver
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted10, with length limits
- commentariesCommentaries WORD LIMIT: 1500Length not stated
- commentaryWORD LIMIT: 1500ABSTRACT: N/AMAIN TEXT: evidence-based opinion pieces involving areas of broad interest.RESEARCH REPORTING CHECKLIST: N/ALength not stated
- editorialThe acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated…Length not stated
- letters to the editorWORD LIMIT: 600ABSTRACT: N/AMAIN TEXT: Letters should be succinct and must relate to an article that has been published in the Journal. The Editor reserves the …Length not stated
- original paperOriginal articles, which report on new research findings or conceptual analyses that make a significant contribution to knowledge will be considered for publica…main text ≤ 4,000 words · abstract ≤ 200 words
- original papersOriginal Papers Original articles, which report on new research findings or conceptual analyses that make a significant contribution to knowledge will be consid…Length not stated
- registered reportEuropean Journal of Cancer Care welcomes Registered Reports. This is a new article type designed to increase the transparency and reproducibility of hypothesis-…Length not stated
- registered reportsRegistered Reports European Journal of Cancer Care welcomes Registered Reports.Length not stated
- reviewWORD LIMIT: 5000ABSTRACT: A structured abstract is required (200 words maximum) under the following sub-headings: Introduction, Methods, Results, Conclusion.MAI…main text ≤ 200 words · abstract ≤ 200 words
- review papersReview Papers WORD LIMIT: 5000Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, Peer review, Preprints, Trial registration / reporting guidelines
- Authorship Authorship
The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potent…
Source ↗Publisher website ·- Publication ethics Publication Ethics
Member of COPE. Model summary
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- Peer review
Peer review is double-blind except where otherwise stated. Model summary
Except where otherwise stated, manuscripts are double-blind peer reviewed.
Source ↗Publisher website ·- Preprints
Preprint policy: preprints may be submitted and posted at any time. Model summary
The European Journal of Cancer Care will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database such as http://clinicaltrials.gov/ and clinical trial registration numbers should be included in all papers that report their results. Clinical trials are defined as interventional studies. Authors are asked to include the name of the trial register and the clinical trial registration number at…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1991
- ISSN
- 0961-5423
- Electronic ISSN
- 1365-2354
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Journal of Cancer Care
What CAS zone is European Journal of Cancer Care in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Cancer Care is in Zone 4 of Medicine, and in Zone 3 of the minor category Nursing / Health Care Sciences & Services / Oncology / Rehabilitation. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Cancer Care?
The latest impact factor listed by LetPub is 1; CiteScore 4.4, h-index 104.
How long does peer review take at European Journal of Cancer Care?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 188 days (interquartile range 127–250 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of European Journal of Cancer Care?
According to the journal's author guidelines: Abstract: ≤ 200 words; Manuscript length: ≤ 4,000 words; Reference style: Vancouver; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index European Journal of Cancer Care?
According to LetPub and DOAJ records, European Journal of Cancer Care is indexed in SCIE, SSCI and Scopus.
Is European Journal of Cancer Care open access, and what is the APC?
European Journal of Cancer Care is a subscription journal. APC about USD 2,490.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .